REQUEST A DEMO
Total
USD $0.00
Search more companies

Phytopharma CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phytopharma CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

phytopharma is an Ecuadorian corporation with over 20 years of experience in producing, representing, and marketing natural medicinal and dermocosmetic products with pharmaceutical quality. They offer standardized phytopharmaceutical therapeutic solutions to the Ecuadorian medical body, following European manufacturing methodology and BPM's standards. One of their products, Immunogalen, supports and balances the healthy immune system.

Headquarters
Av Manuel Cordova Galarza Oe8-669
Quito; Pichincha;

Contact Details: Purchase the Phytopharma CIA Ltda report to view the information.

Website: http://www.phytopharma.com.ec

Basic Information
Total Employees:
Purchase the Phytopharma CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Phytopharma CIA Ltda report to view the information.
Registered Capital:
Purchase the Phytopharma CIA Ltda report to view the information.
Incorporation Date:
July 03, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Phytopharma CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-73.57%
Total operating revenue
-67.49%
Operating profit (EBIT)
-71.44%
EBITDA
-67.87%
Net Profit (Loss) for the Period
-78.99%
Total assets
-95.17%
Total equity
38.45%
Operating Profit Margin (ROS)
0.25%
Net Profit Margin
-0.41%
Return on Equity (ROE)
-155.28%
Quick Ratio
11.59%
Cash Ratio
1.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?